■ Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
Winfried M. Amoaku, Faruque Ghanchi, Clare Bailey, et al
Eye (Lond) 2020, vol 34(Suppl 1): 1–51
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7337227/
■ Recent advancement in the medical treatment of diabetic retinal disease
Maja Szymanska, Daanyaal Mahmood, Timothy E. Yap, Maria F. Cordeiro
Int J Mol Sci.2021, vol 22(17): 9441
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8430918/
■ Diabetic retinopathy in the aging population: a perspective of pathogenesis and treatment
Sameer P Leley, Thomas A Ciulla, Ashay D Bhatwadekar
Clin Interv Aging.2021;, vol 16: 1367–137
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8289197/
■ Diabetes mellitus e suas complicações – uma revisão sistemática e informativa
R M F de Castro, A M N Silva, A K S da Silva et al
Brazilian Jou 2021, vol 4 (1)
https://www.brazilianjournals.com/index.php/BJHR/article/view/24958/19902
■ Role of oral antioxidant supplementation in the current management of diabetic retinopathy
Enrique Antonio Alfonso-Muñoz, Raquel Burggraaf-Sánchez de las Matas, Jorge Mataix Boronat et al
Int J Mol Sci.2021, vol 22(8): 4020
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8069935/
■ An evidence map of clinical practice guideline recommendations and quality on diabetic retinopathy
Y Sun, T Cai, J Chen et al
Eye (Lond) 2020, vol 34 (11): 1989-2000
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7784673/
■ Intravitreal anti-vascular endothelial growth factor agents for the treatment of diabetic retinopathy: a review of the literature
Irini Chatziralli, Anat Loewenstein
Pharmaceutics.2021, vol 13(8): 1137
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8399287/
■ The safety of pharmacological and surgical treatment of diabetes in patients with diabetic retinopathy – a review
Wojciech Matuszewski, Angelika Baranowska-Jurkun, Magdalena Maria Stefanowicz-Rutkowska et al
J Clin Med.2021, vol 10(4): 705
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7916896/
■ A systematic review of carotenoids in the management of diabetic retinopathy
Drake W. Lem, Dennis L. Gierhart, Pinakin Gunvant Davey
Nutrients.2021, vol 13(7): 2441
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8308772/
■ Emerging roles of dylipidemia and hyperglycemia in diabetic retinopathy: molecular mechanisms and clinical perspectives
Hussain Rao, Jonathan A. Jalali, Thomas P. Johnston, Peter Koulen
Front Endocrinol (Lausanne) 2021; vol 12: 620045
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8020813/
■ HBA1c change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcomes trials: a meta-analysis and meta-regression
M A Bethel, R Diaz, N Casttellana et al
Diabetes Care 2021, vol 44 (1): 290-296
https://care.diabetesjournals.org/content/44/1/290
■ Review of the management of sight-threatening diabetic retinopathy during pregnancy
P P Choo, N Din, N Azmi et al
World J Diabetes 2021, vol 12 (9): 1386-1400
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8472492/
■ Celular targets in diabetic retinopathy therapy
M L Rodríguez, I Millán A L Ortega
World J Diabetes 2021, vol12 (9): 1442-1462
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8472497/
■ Epigenetic mechanism in type 2 diabetes retinopatht: a systematic review
Agostino Milluzzo, Andrea Maugeri, Martina Barchitta et al
Int J Mol Sci.2021, vol 22(19): 10502
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8509039/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Blog Internet Médica – www.internetmedica.com.br
Data: novembro 2021